Associated Papers
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer.
Tan S et al.
Cancer, 2025
39876053 (PubMed )
Supplement: supplement_1.pdf
Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma.
Tessiri S et al.
Peerj, 2022
35070505 (PubMed )
Supplement: peerj-10-12750-s003.xlsx › Supplemental_Table1
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
Cobain EF et al.
Jama Oncology, 2021
33630025 (PubMed )
Supplement: jamaoncol-e207987-s004.xlsx › Table
Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.
Wang Y et al.
Plos One, 2020
ARID1A alterations and their clinical significance in cholangiocarcinoma.
Namjan A et al.
Peerj, 2020
33344089 (PubMed )
Supplement: peerj-08-10464-s002.xlsx › Table_S2
Select a paper to view details